An Open-Label, Ascending, Two-Part, Single- and Multiple-Dose Evaluation of the Safety, Pharmacokinetics, and Effectiveness of Oxymorphone for Acute Postoperatiave Pain in Pediatric Subjects
收藏DataCite Commons2025-02-10 更新2024-07-13 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010224/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
When post-operative parenteral analgesia is discontinued, oral dosing with study medication
may begin once the subject has developed a moderate level of pain as defined by a 100 mm VAS
(pain intensity score greater than or equal to 40).
This post marketing study was required by the FDA. Endo Pharmaceuticals Inc. no longer
promotes opioids and no longer markets Opana® ER.
提供机构：
Vivli
创建时间：
2024-06-21
